A Phase I-II Dose Escalation Trial of Clofarabine Plus Melphalan and Thiotepa Followed by Unmodified Allogeneic Stem Cell Transplant (SCT) for the Treatment of High Risk or Advanced Acute Leukemia

Farid Boulad; Nancy A Kernan; Susan E Prockop; Andromachi Scaradavou; Trudy N Small; Elizabeth G Klein; Juliet Barker; Ann A. Jakubowski; Guenther Koehne; Esperanza Papadopoulos; Miguel-Angel Perales; James W. Young; Richard J. O'Reilly

A Phase I-II Dose Escalation Trial of Clofarabine Plus Melphalan and Thiotepa Followed by Unmodified Allogeneic Stem Cell Transplant (SCT) for the Treatment of High Risk or Advanced Acute Leukemia

Farid Boulad, Nancy A Kernan, Susan E Prockop, Andromachi Scaradavou, Trudy N Small, Elizabeth G Klein, Juliet Barker, Ann A. Jakubowski, Guenther Koehne, Esperanza Papadopoulos, Miguel-Angel Perales, James W. Young, Richard J. O'Reilly

Miami Cancer Institute

Research output: Contribution to conference › Presentation

Original language	American English
State	Published - Nov 19 2010
Event	Blood - Duration: Jan 1 2020 → …

Conference

Conference	Blood
Period	1/1/20 → …

Disciplines

Medicine and Health Sciences
Immunology and Infectious Disease

Cite this

Boulad, F., Kernan, N. A., Prockop, S. E., Scaradavou, A., Small, T. N., Klein, E. G., Barker, J., Jakubowski, A. A., Koehne, G., Papadopoulos, E., Perales, M.-A., Young, J. W., & O'Reilly, R. J. (2010). A Phase I-II Dose Escalation Trial of Clofarabine Plus Melphalan and Thiotepa Followed by Unmodified Allogeneic Stem Cell Transplant (SCT) for the Treatment of High Risk or Advanced Acute Leukemia. Blood.

Boulad, F, Kernan, NA, Prockop, SE, Scaradavou, A, Small, TN, Klein, EG, Barker, J, Jakubowski, AA, Koehne, G, Papadopoulos, E, Perales, M-A, Young, JW & O'Reilly, RJ 2010, 'A Phase I-II Dose Escalation Trial of Clofarabine Plus Melphalan and Thiotepa Followed by Unmodified Allogeneic Stem Cell Transplant (SCT) for the Treatment of High Risk or Advanced Acute Leukemia', Blood, 1/1/20.

@conference{dff3fc17a5504597892c621f585236e7,

title = "A Phase I-II Dose Escalation Trial of Clofarabine Plus Melphalan and Thiotepa Followed by Unmodified Allogeneic Stem Cell Transplant (SCT) for the Treatment of High Risk or Advanced Acute Leukemia",

author = "Farid Boulad and Kernan, \{Nancy A\} and Prockop, \{Susan E\} and Andromachi Scaradavou and Small, \{Trudy N\} and Klein, \{Elizabeth G\} and Juliet Barker and Jakubowski, \{Ann A.\} and Guenther Koehne and Esperanza Papadopoulos and Miguel-Angel Perales and Young, \{James W.\} and O'Reilly, \{Richard J.\}",

note = "Abstract 2354 High-risk or advanced acute leukemias are associated with poor outcome even with the use of stem cell transplantation (SCT) with or without total body irradiation (TBI).; Blood ; Conference date: 01-01-2020",

year = "2010",

month = nov,

day = "19",

language = "American English",

}

TY - CONF

T1 - A Phase I-II Dose Escalation Trial of Clofarabine Plus Melphalan and Thiotepa Followed by Unmodified Allogeneic Stem Cell Transplant (SCT) for the Treatment of High Risk or Advanced Acute Leukemia

AU - Boulad, Farid

AU - Kernan, Nancy A

AU - Prockop, Susan E

AU - Scaradavou, Andromachi

AU - Small, Trudy N

AU - Klein, Elizabeth G

AU - Barker, Juliet

AU - Jakubowski, Ann A.

AU - Koehne, Guenther

AU - Papadopoulos, Esperanza

AU - Perales, Miguel-Angel

AU - Young, James W.

AU - O'Reilly, Richard J.

N1 - Abstract 2354 High-risk or advanced acute leukemias are associated with poor outcome even with the use of stem cell transplantation (SCT) with or without total body irradiation (TBI).

PY - 2010/11/19

Y1 - 2010/11/19

UR - http://www.bloodjournal.org/content/116/21/2354?sso-checked=true

M3 - Presentation

T2 - Blood

Y2 - 1 January 2020

ER -

A Phase I-II Dose Escalation Trial of Clofarabine Plus Melphalan and Thiotepa Followed by Unmodified Allogeneic Stem Cell Transplant (SCT) for the Treatment of High Risk or Advanced Acute Leukemia

Conference

Disciplines

Other files and links

Cite this